Users Coming Off Weight-Loss Medications Regain Pounds Far More Rapidly Compared to People Using Diet and Exercise

New research indicates that people who discontinue new GLP-1 drugs like Wegovy and Mounjaro may regain lost weight much more quickly than those who stop traditional diet and exercise programs.

Findings released in a leading medical journal demonstrates that while obese individuals can lose a large proportion of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"Users buying these drugs must be aware of the risk of quick weight regain when the medication concludes," stated expert Dr. Susan Jebb.

That rate of recovery suggests a return to pre-treatment weight in about a year and a half.

Weighing Approaches

The analysis, which examined dozens of studies involving thousands of participants, compared the outcomes of these new drugs with other pills.

Scientists emphasize that people who shed pounds through lifestyle changes alone generally experience a less rapid creep back—around 0.1 kg a month—after stopping.

The Reason for the Rapid Regain

Nutrition scientists suggest the mechanism of the injections explains the amplified weight return.

GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Artificially providing the hormone levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this medication results in appetite is unsuppressed, making overeating far more likely."

A Chronic Condition?

Medical guidelines suggest the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts say that, given the likelihood of weight regain, the treatment is often long-term.

This perspective is echoed by drug manufacturers, who state that the findings "underscore the long-term character of excess weight," akin to managing diseases like diabetes.

User Experiences

Users who have stopped the medication report a intense resurgence of hunger.

"It felt as if a switch that goes on and I was suddenly extremely hungry," said an individual.

This difficulty is exacerbated if individuals have not adopted lasting dietary or behavioural modifications during therapy.

Significant Use

Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.

• Adoption is greater among females than males.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion access the drugs through private healthcare rather than the NHS.

Finally, experts stress that while these medications are potent agents for weight loss, they are not a standalone solution and maintained weight loss likely depends on ongoing behavioural management.